Zhi Gang Luo
Chief Executive Officer chez YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.
Profil
Zhi Gang Luo is currently the Chairman & General Manager at JYAMS PET Research & Development Ltd.
He is also the Chairman at MITRO Biotech Co., Ltd.
and the General Manager & Director at Yantai Dongcheng Biochemicals Co., Ltd.
Additionally, he holds the position of Executive Director at Shanghai Lanacheng Biotechnology Co., Ltd.
and Director at Aprinoia Therapeutics, Inc. He has previously worked as the Deputy General Manager & Manager at Beijing AMS Electronics Co.,Ltd.
In terms of education, Mr. Luo holds an MBA from Beijing University of Posts & Telecommunications, which he obtained in 2003.
He also has an undergraduate degree from Southern Medical University, which he received in 1992.
Postes actifs de Zhi Gang Luo
| Sociétés | Poste | Début |
|---|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Chief Executive Officer | 14/12/2021 |
JYAMS PET Research & Development Ltd.
 JYAMS PET Research & Development Ltd. Pharmaceuticals: MajorHealth Technology JYAMS PET Research & Development Ltd. engages in the production and sales of radiopharmaceuticals. Its business includes technology development and technology transfer of positron tracer and molecular probe. The company was founded on March 7, 2006 and is headquartered in Nanjing, China. | Chief Executive Officer | - |
Shanghai Lanacheng Biotechnology Co., Ltd.
 Shanghai Lanacheng Biotechnology Co., Ltd. Packaged SoftwareTechnology Services Founded in 2021, Shanghai Lanacheng Biotechnology Co., Ltd. is a subsidiary of Yantai Dongcheng Biochemicals Co., Ltd. that provides technology solution services. The private company is based in Shanghai, China. | Director/Board Member | - |
Mitro Biotech Co., Ltd.
 Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Chairman | 25/07/2020 |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | 01/06/2021 |
| Beijing Ams Electronics Co.,Ltd. | Corporate Officer/Principal | - |
Formation de Zhi Gang Luo
| Beijing University of Posts & Telecommunications | Masters Business Admin |
| Southern Medical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
JYAMS PET Research & Development Ltd.
JYAMS PET Research & Development Ltd. Pharmaceuticals: MajorHealth Technology JYAMS PET Research & Development Ltd. engages in the production and sales of radiopharmaceuticals. Its business includes technology development and technology transfer of positron tracer and molecular probe. The company was founded on March 7, 2006 and is headquartered in Nanjing, China. | Health Technology |
Mitro Biotech Co., Ltd.
Mitro Biotech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Mitro Biotech Co., Ltd. engages in contract research for new drug development using radiolabeling and molecular imaging technique. It offers drug screening, biodistribution, pharmacokinetics, pharmacodynamics, translational research service, pre-clinical services, clinical services, and regulatory services. The company was founded on November 29, 2012 and is headquartered in Nanjing, China. | Commercial Services |
Shanghai Lanacheng Biotechnology Co., Ltd.
Shanghai Lanacheng Biotechnology Co., Ltd. Packaged SoftwareTechnology Services Founded in 2021, Shanghai Lanacheng Biotechnology Co., Ltd. is a subsidiary of Yantai Dongcheng Biochemicals Co., Ltd. that provides technology solution services. The private company is based in Shanghai, China. | Technology Services |
| Beijing Ams Electronics Co.,Ltd. | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
